|
|
345 Park Avenue New York, NY 10154-0037 USA phone:800-332-2056 fax:(212) 546-4020
|
|
| Symbol |
BMY |
| Exchange |
NYSE |
| Founded |
1858 |
| Employees |
44000 |
|
|
| www.bms.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Bristol-Myers produces and distributes healthcare-related products and pharmaceuticals. |
 |
| Management |
| James M. Cornelius, Chairman & CEO; Sandra Leung, Senior Vice President, General Counsel & Corporate Secretary; Lamberto Andreotti, President & Chief Operating Officer; Elliott Sigal, Executive Vice President, Chief Scientific Officer & President, R&D; Charles Bancroft, Acting Chief Financial Officer |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| therapeutic, abatacept, emtricitabine, cetuximab, orencia |
|
|
|
|
|
|
| Description |
|
Bristol-Myers Squibb Company is a producer and distributor of pharmaceuticals and other healthcare-related products. The Company has three reportable segments: Pharmaceuticals, Nutritionals and Other ...
view more
|
 |
 |
|
|
|
|
|
|